We thank Aud Eliassen at the sequencing laboratory at Haukeland University Hospital, Bergen, Norway. We thank Cecilie Køhler (Dept. of clinical science 2, University of Bergen), Diana Mahelai and Salesh Chandran (St. John's Research Institute) for technical assistance. Sumithra Selvan, Nelson Jesuraj and Naveen Kumar Kellengere at St. John's Research Institute, Bangalore are thanked for epidemiological data and for statistical assistance. This study is conducted as part of the Indo-Norway research program. Contributors: TB Trials Study Group: Doherty TM (Glaxo- SmithKline, Copenhagen, Denmark) Grewal HMS (coordinator of TB Trials, Department of Clinical Science, Faculty of Medicine and Dentistry, University of Bergen, Norway and Department of Microbiology, Haukeland University Hospital, Bergen, Norway), Lindtjørn B, (University of Bergen, Norway), Hesseling AC (Desmond Tutu TB Center, Cape Town, South Africa), Jacob A (Emmaus Swiss Leprosy Project, Palamaner, India), Jahnsen FL (Department of Pathology and Center for Immune Regulation, Oslo University Hospital, Rikshospitalet, Oslo, Norway), Kenneth J, Srinivasan K, Macaden R, Nelson J, Sumithra S, Vaz M (St. John's Research Institute, Koramangala, Bangalore, India), Cardenas V (Aeras, Rockville, USA).